Protein contamination of the Laryngeal Mask Airway and its relationship to re-use

Anaesthesia and Intensive Care

Volumn 34, Issue 3, 2006, Pages 343-346

  Greenwood, J ^a   Green, N ^b   Power, Gerald ^b  

^a PRINCESS ALEXANDRA HOSPITAL   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Creutzveldt Jacob disease; Decontamination; Laryngeal mask airway; Prions; Protein contamination; Sterilization

Indexed keywords

PRION PROTEIN;

ARTICLE; CLEANING; CONTAMINATION; CONTROLLED STUDY; CREUTZFELDT JAKOB DISEASE; DISPOSABLE EQUIPMENT; GENERAL ANESTHESIA; INSTRUMENT STERILIZATION; LARYNGEAL MASK; LINEAR REGRESSION ANALYSIS; PACKAGING; QUANTITATIVE ANALYSIS; RECYCLING; STAINING;

EID: 33745666703     PISSN: 0310057X     EISSN: None     Source Type: Journal    
DOI: 10.1177/0310057x0603400312     Document Type: Article

References (14)

1. The Laryngeal Mask Company http://www.1mana.com 2005.
2. Miller D, Youkhana I, Karunartne W et al. Presence of protein deposits on 'cleaned' re-usable anaesthetic equipment. Anaesthesia 2001; 56:1069-1072.
3. Clery G, Brimacombe J, Stone T et al. Routine cleaning and autoclaving does not remove protein deposits from reusable laryngeal mask devices. Anaesth Analg 2003; 97:1189-1191.
4. Coetzee G. Eliminating protein from reusable laryngeal mask airways. A study coparing routinely cleaned masks with three alternative cleaning methods. Anaesthesia 2003; 58:346-353.
5. Ramasamy I. The risk of accidental transmission of transmissable spongiform encephalopathy: identification of emerging issues. Public Health 2004; 118:409-420.
6. Will R, Ironside JW, Zeilder M et al. A new variant of Creutzfeldt-Jacob disease in the UK. Lancet 1996; 347:921-925.
7. Head MW, Ritchie D, Smith N et al. Peripheral tissue involvement in sporadic, iatrogenic, and variant Creutzfeldt-Jakob disease: an immunohistochemical, quantitative, and biochemical study. Am J Pathol 2004; 164:143-153.
8. Fichet G, Comoy E, Duval C et al. Novel method for disinfection of prion-contaminated medical devices. Lancet 2004; 364:521-526.
9. WHO Infection Control Guidelines for Transmissible Spongiform Encephalopathies Report of a WHO Consultation Geneva, Switzerland. Geneva: World Health Organisation 1999.
10. Soedak HS. Colorimetric micromethod for protein determination with Erythrosin B. B Anal Biochein 1994; 220:142-148.
11. Prusiner SB. Prion diseases and the BSE crisis. Science 1997; 278:245-251.
12. Hill AF, Butterworth RJ, Joiner S et al. Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples. Lancet 1999; 353:183-189.
13. Frosh A, Joyce R, Johnson A. Iatrogenic vCJD from surgical instruments. BMJ 2001; 322:1558-1559.
14. Valleron AJ, Boelle PY, Will R, Cesbron JY. Estimation of epidemic size and incubation time based on age characteristics of vCJD in the United Kingdom. Science 2001; 294:1726-1728.